China · Delayed Price · Currency is CNY Walvax Biotechnology Statistics
Total Valuation
SHE:300142 has a market cap or net worth of CNY 19.56 billion. The enterprise value is 19.41 billion.
| Market Cap | 19.56B |
| Enterprise Value | 19.41B |
Important Dates
The last earnings date was Wednesday, October 29, 2025.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | May 28, 2025 |
Share Statistics
SHE:300142 has 1.60 billion shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 1.60B |
| Shares Outstanding | 1.60B |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +1.90% |
| Owned by Insiders (%) | 7.60% |
| Owned by Institutions (%) | 15.60% |
| Float | 1.43B |
Valuation Ratios
The trailing PE ratio is 397.20 and the forward PE ratio is 56.88.
| PE Ratio | 397.20 |
| Forward PE | 56.88 |
| PS Ratio | 8.15 |
| PB Ratio | 1.79 |
| P/TBV Ratio | 2.22 |
| P/FCF Ratio | 206.27 |
| P/OCF Ratio | 35.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 154.33, with an EV/FCF ratio of 204.69.
| EV / Earnings | 394.17 |
| EV / Sales | 8.09 |
| EV / EBITDA | 154.33 |
| EV / EBIT | n/a |
| EV / FCF | 204.69 |
Financial Position
The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.52 |
| Quick Ratio | 2.60 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 2.16 |
| Debt / FCF | 2.87 |
| Interest Coverage | -421.32 |
Financial Efficiency
Return on equity (ROE) is -0.64% and return on invested capital (ROIC) is -1.68%.
| Return on Equity (ROE) | -0.64% |
| Return on Assets (ROA) | -1.41% |
| Return on Invested Capital (ROIC) | -1.68% |
| Return on Capital Employed (ROCE) | -2.75% |
| Revenue Per Employee | 1.00M |
| Profits Per Employee | 20,622 |
| Employee Count | 2,388 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.08 |
Taxes
In the past 12 months, SHE:300142 has paid 19.72 million in taxes.
| Income Tax | 19.72M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.97% in the last 52 weeks. The beta is 0.45, so SHE:300142's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -16.97% |
| 50-Day Moving Average | 12.14 |
| 200-Day Moving Average | 11.52 |
| Relative Strength Index (RSI) | 62.19 |
| Average Volume (20 Days) | 26,465,980 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300142 had revenue of CNY 2.40 billion and earned 49.24 million in profits. Earnings per share was 0.03.
| Revenue | 2.40B |
| Gross Profit | 1.61B |
| Operating Income | -317.99M |
| Pretax Income | -53.01M |
| Net Income | 49.24M |
| EBITDA | 100.82M |
| EBIT | -317.99M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 1.68 billion in cash and 272.24 million in debt, giving a net cash position of 1.41 billion or 0.88 per share.
| Cash & Cash Equivalents | 1.68B |
| Total Debt | 272.24M |
| Net Cash | 1.41B |
| Net Cash Per Share | 0.88 |
| Equity (Book Value) | 10.94B |
| Book Value Per Share | 6.05 |
| Working Capital | 4.23B |
Cash Flow
In the last 12 months, operating cash flow was 556.81 million and capital expenditures -461.98 million, giving a free cash flow of 94.83 million.
| Operating Cash Flow | 556.81M |
| Capital Expenditures | -461.98M |
| Free Cash Flow | 94.83M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 67.22%, with operating and profit margins of -13.26% and 2.05%.
| Gross Margin | 67.22% |
| Operating Margin | -13.26% |
| Pretax Margin | -2.21% |
| Profit Margin | 2.05% |
| EBITDA Margin | 4.20% |
| EBIT Margin | -13.26% |
| FCF Margin | 3.95% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.08%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.08% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 32.47% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.10% |
| Earnings Yield | 0.25% |
| FCF Yield | 0.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 14, 2015. It was a forward split with a ratio of 3.
| Last Split Date | Oct 14, 2015 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
SHE:300142 has an Altman Z-Score of 5.94 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.94 |
| Piotroski F-Score | 5 |